Literature DB >> 25046360

An increased proportion of circulating Th22 and Tc22 cells in psoriasis.

Li Luan1, Ying Ding1, Shixin Han1, Zhenying Zhang2, Xiaoming Liu3.   

Abstract

Psoriasis is a common dermatosis mediated by T cells. This study investigated the correlation of Th22 cells and Tc22 cells with psoriasis. A total of 30 psoriasis patients and 11 age- and sex-matched healthy controls were recruited for this study. The proportions of circulating Th22 and Tc22 cells, expression of aryl hydrocarbon receptor, and IL-22 levels in the psoriasis patients were significantly higher than those in the control subjects (p<0.05). There was a positive correlation between the proportion of circulating Th22 cells, IL-22 levels, and PASI score. The IL-22 levels and PASI score were also positively correlated. There was no correlation between the proportion of circulating Tc22 cells and IL-22 level or PASI score. These data are consistent with Th22 cells involvement in the pathogenesis of psoriasis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AHR; IL-22; Psoriasis; Tc22 cell; Th22 cell

Mesh:

Substances:

Year:  2014        PMID: 25046360     DOI: 10.1016/j.cellimm.2014.06.007

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

Review 1.  CD8(+) T cells in human autoimmune arthritis: the unusual suspects.

Authors:  Alessandra Petrelli; Femke van Wijk
Journal:  Nat Rev Rheumatol       Date:  2016-06-03       Impact factor: 20.543

Review 2.  A gradient of glucocorticoid sensitivity among helper T cell cytokines.

Authors:  Jesus Banuelos; Nicholas Z Lu
Journal:  Cytokine Growth Factor Rev       Date:  2016-05-13       Impact factor: 7.638

3.  Altered expression of regulatory molecules in the skin of psoriasis.

Authors:  A D Sabag; D Dias-Polak; J Bejar; H Sheffer; R Bergman; Zahava Vadasz
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

4.  In vitro psoriasis models with focus on reconstructed skin models as promising tools in psoriasis research.

Authors:  Eline Desmet; Anesh Ramadhas; Jo Lambert; Mireille Van Gele
Journal:  Exp Biol Med (Maywood)       Date:  2017-06

Review 5.  Aryl Hydrocarbon Receptors: Evidence of Therapeutic Targets in Chronic Inflammatory Skin Diseases.

Authors:  Han-Bi Kim; Ji-Young Um; Bo-Young Chung; Jin-Cheol Kim; Seok-Young Kang; Chun-Wook Park; Hye-One Kim
Journal:  Biomedicines       Date:  2022-05-07

6.  MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation.

Authors:  Ruifang Wu; Jinrong Zeng; Jin Yuan; Xinjie Deng; Yi Huang; Lina Chen; Peng Zhang; Huan Feng; Zixin Liu; Zijun Wang; Xiaofei Gao; Haijing Wu; Honglin Wang; Yuwen Su; Ming Zhao; Qianjin Lu
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

7.  Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis Vulgaris.

Authors:  Emiliano Antiga; Veronica Bonciolini; Walter Volpi; Elena Del Bianco; Marzia Caproni
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

Review 8.  Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases.

Authors:  Qi Jiang; Guocan Yang; Fan Xiao; Jue Xie; Shengjun Wang; Liwei Lu; Dawei Cui
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

9.  Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus.

Authors:  Rosana Domingues; Gabriel Costa de Carvalho; Valéria Aoki; Alberto José da Silva Duarte; Maria Notomi Sato
Journal:  J Transl Med       Date:  2016-06-10       Impact factor: 5.531

10.  Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo.

Authors:  Ulf Guendisch; Jessica Weiss; Florence Ecoeur; Julia Christina Riker; Klemens Kaupmann; Joerg Kallen; Samuel Hintermann; David Orain; Janet Dawson; Andreas Billich; Christine Guntermann
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.